1,10-Phenanthroline → 3-{[2-(4-Amino-furazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenol

HRID 1986374노트

반응식

HRID 1986374 반응식
C([Si](C)(C)[O:6][C:7]1[CH:8]=[C:9]([OH:13])[CH:10]=[CH:11][CH:12]=1)(C)(C)C.Br[C:17]1[N:22]=[CH:21][C:20]2[N:23]=[C:24]([C:28]3[C:29]([NH2:33])=[N:30][O:31][N:32]=3)[N:25]([CH2:26][CH3:27])[C:19]=2[CH:18]=1.N1C2C(=CC=C3C=2N=CC=C3)C=CC=1.C(=O)([O-])[O-].[Cs+].[Cs+]>C1(C)C=CC=CC=1>[NH2:33][C:29]1[C:28]([C:24]2[N:25]([CH2:26][CH3:27])[C:19]3[CH:18]=[C:17]([O:6][C:7]4[CH:8]=[C:9]([OH:13])[CH:10]=[CH:11][CH:12]=4)[N:22]=[CH:21][C:20]=3[N:23]=2)=[N:32][O:31][N:30]=1

참가 물질

6

반응물 4

HCID 13181,10-PhenanthrolineHCID 10796Cesium carbonateHCID 114474403-[(Tert-butyldimethylsilyl)oxy]phenolHCID 160998514-(6-Bromo-1-Ethyl-1h-Imidazo[4,5-C]pyridin-2-Yl)-1,2,5-Oxadiazol-3-Amine

생성물 1

HCID 113711573-{[2-(4-Amino-furazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenol수율 7%

시약·촉매·용매 1

HCID 1140Toluene용매

반응 조건

온도
120 °C

실험 절차

The product from Step 1 (46 mg, 0.20 mmol) in toluene (10 mL) was treated with the product from Step 2 (42 mg, 0.14 mmol), cuprous iodide (26 mg, 0.14 mmol), 1,10-phenanthroline (43 mg, 0.24 mmol), and cesium carbonate (88 mg, 0.27 mmol). The resulting mixture was heated to 120° C. for 48 hours in a sealed tube. After concentration the residue was purified by reverse phase HPLC to give the title compound (3.3 mg, 7%). MS (ES+) m/e 339 [M+H]+.

후처리

  1. concentrationAfter concentration the residue
  2. customwas purified by reverse phase HPLC

출처 및 근거

ORD 기록
ord-e1cbc58a817a4abe81eebe57cd48ce10
출처 데이터셋
uspto-grants-2009_06
특허 번호
US07547779B2

반응 노트

불러오는 중…